Matt focuses on the firm's healthcare research efforts and is responsible for monitoring positions related to the sector for the Bailard all cap growth/technology and science equity strategy and the firm's private emerging life sciences strategy.

Previously, he focused on Bailard's fixed income and asset allocation efforts and trading desk duties. Before joining Bailard in 2001, he worked as a new business analyst at Conseco Financial Services.

Matt received his BA in biology from DePauw University in 2000. Outside of Bailard, Matt enjoys cycling, traveling, skiing and Kansas Jayhawk basketball.